DIAGNOSIS OF PSEUDOPROGRESSION FOLLOWING RADIOTHERAPY PLUS LOMUSTINE-TEMOZOLOMIDE CHEMOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS USING FET PET

被引：0
|
作者：
Werner, Jan-Michael [1 ,2 ]
Ceccon, Garry [1 ,2 ]
Weller, Johannes [3 ]
Schaub, Christina [3 ]
Tscherpel, Caroline [1 ,2 ]
Lohmann, Philipp [4 ]
Bauer, Elena [1 ,2 ]
Schaefer, Niklas [3 ]
Stoffels, Gabriele [4 ]
Kabbasch, Christoph [2 ,5 ]
Baues, Christian [2 ,6 ]
Marnitz, Simone [2 ,6 ]
Fink, Gereon R. [1 ,2 ]
Langen, Karl-Josef [4 ]
Herrlinger, Ulrich [3 ]
Galldiks, Norbert [1 ,2 ]
机构：
[1] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Univ Hosp Bonn, Dept Neurol, Div Clin Neurooncol, Bonn, Germany
[4] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany
[5] Univ Cologne, Fac Med, Dept Neuroradiol, Cologne, Germany
[6] Univ Cologne, Fac Med, Dept Radiat Oncol, Cologne, Germany
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NIMG-26
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [11] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [12] Combination Therapy of Lomustine and Temozolomide in Patients with newly diagnosed Glioblastoma with methylated MGMT Promotor
    Lenzen, Julia
    Feldmann, H. J.
    ONKOLOGE, 2019, 25 (12): : 1118 - 1120
  • [13] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [14] PSEUDOPROGRESSION (PSPR) AFTER CONCURRENT RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Clarke, Jennifer
    Abrey, Lauren
    Karimi, Sasan
    Lassman, Andrew
    NEURO-ONCOLOGY, 2008, 10 (05) : 893 - 893
  • [15] Pseudoprogression (PsPr) after concurrent radiotherapy (RT) and temozolomide (TMZ) for newly diagnosed glioblastoma multiforme (GBM)
    Clarke, J. L.
    Abrey, L. E.
    Karimi, S.
    Lassman, A. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [16] FET PET RADIOMICS - DIAGNOSIS OF PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS BASED ON TEXTURAL FEATURES
    Lohmann, P.
    Lerche, C.
    Stoffels, G.
    Filss, C. P.
    Stegmayr, C.
    Neumaier, B.
    Shah, N. J.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2017, 19 : 75 - 75
  • [17] Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide
    Glas, Martin
    Happold, Caroline
    Rieger, Johannes
    Wiewrodt, Dorothee
    Baehr, Oliver
    Steinbach, Joachim P.
    Wick, Wolfgang
    Kortmann, Rolf-Dieter
    Reifenberger, Guido
    Weller, Michael
    Herrlinger, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1257 - 1261
  • [18] Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
    Vieito, Maria
    Simonelli, Matteo
    de Vos, Filip
    Moreno, Victor
    Geurts, Marjolein
    Lorenzi, Elena
    Macchini, Marina
    van den Bent, Martin J.
    Del Conte, Gianluca
    de Jonge, Maja
    Martin-Soberon, Maria Cruz
    Amoroso, Barbara
    Sanchez-Perez, Tania
    Zuraek, Marlene
    Hanna, Bishoy
    Aronchik, Ida
    Filvaroff, Ellen
    Chang, Henry
    Mendez, Cristina
    Arias Parro, Marina
    Wei, Xin
    Nikolova, Zariana
    Sepulveda, Juan Manuel
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [19] A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Fiveash, John
    Nabors, Louis B.
    Mikkelsen, Tom
    Peereboom, David M.
    Lesser, Glenn J.
    Chowdhary, Sajeel A.
    Grossman, Stuart
    Ye, Xiaubu
    Leopold, Lance
    Rosenfeld, Myrna
    NEURO-ONCOLOGY, 2009, 11 (05) : 666 - 666
  • [20] ANALYSIS OF TUMOR RELAPSE PROBABILITY AND OVERALL SURVIVAL PREDICTION FOLLOWING CONCOMITANT RADIOTHERAPY WITH TEMOZOLOMIDE USING FET PET IN PATIENTS WITH GLIOBLASTOMA
    Stetter, I
    Werner, J.
    Wollring, M.
    Ceccon, G.
    Lohmann, P.
    Stoffels, G.
    Mottaghy, F. M.
    Fink, G. R.
    Langen, K.
    Galldiks, N.
    NEURO-ONCOLOGY, 2024, 26
12345